These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 22653249)

  • 1. Catheter-based renal sympathetic denervation for the treatment of resistant hypertension: first experience in Greece with significant ambulatory blood pressure reduction.
    Tsioufis C; Dimitriadis K; Tsiachris D; Thomopoulos C; Kasiakogias A; Kordalis A; Kefala A; Kallikazaros I; Stefanadis C
    Hellenic J Cardiol; 2012; 53(3):237-41. PubMed ID: 22653249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of renal sympathetic denervation on cardiac sympathetic activity and function in patients with therapy resistant hypertension.
    van Brussel PM; Eeftinck Schattenkerk DW; Dobrowolski LC; de Winter RJ; Reekers JA; Verberne HJ; Vogt L; van den Born BJ
    Int J Cardiol; 2016 Jan; 202():609-14. PubMed ID: 26447672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catheter-based renal denervation for resistant hypertension: Twenty-four month results of the EnligHTN I first-in-human study using a multi-electrode ablation system.
    Tsioufis CP; Papademetriou V; Dimitriadis KS; Kasiakogias A; Tsiachris D; Worthley MI; Sinhal AR; Chew DP; Meredith IT; Malaiapan Y; Thomopoulos C; Kallikazaros I; Tousoulis D; Worthley SG
    Int J Cardiol; 2015 Dec; 201():345-50. PubMed ID: 26301677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catheter-based renal denervation for drug-resistant hypertension by using a standard electrophysiology catheter.
    Prochnau D; Lucas N; Kuehnert H; Figulla HR; Surber R
    EuroIntervention; 2012 Jan; 7(9):1077-80. PubMed ID: 21959556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights on safety and efficacy of renal artery denervation for uncontrolled-resistant hypertension in a high risk population with chronic kidney disease: first Italian real-world experience.
    Marin F; Fezzi S; Gambaro A; Ederle F; Castaldi G; Widmann M; Gangemi C; Ferrero V; Pesarini G; Pighi M; Ribichini FL
    J Nephrol; 2021 Oct; 34(5):1445-1455. PubMed ID: 33481223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term follow-up after radio-frequency catheter-based denervation in patients with resistant hypertension.
    Skowerski M; Roleder T; Bańska-Kisiel K; Pysz P; Ochała A; Wojakowski W; Gąsior Z
    Int J Cardiol; 2016 Jul; 215():472-5. PubMed ID: 27131767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal denervation with a percutaneous bipolar radiofrequency balloon catheter in patients with resistant hypertension: 6-month results from the REDUCE-HTN clinical study.
    Sievert H; Schofer J; Ormiston J; Hoppe UC; Meredith IT; Walters DL; Azizi M; Diaz-Cartelle J; Cohen-Mazor M
    EuroIntervention; 2015 Feb; 10(10):1213-20. PubMed ID: 25452197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal denervation improves exercise blood pressure: insights from a randomized, sham-controlled trial.
    Fengler K; Heinemann D; Okon T; Röhnert K; Stiermaier T; von Röder M; Besler C; Müller U; Höllriegel R; Schuler G; Desch S; Lurz P
    Clin Res Cardiol; 2016 Jul; 105(7):592-600. PubMed ID: 26728060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Renal denervation a treatment for resistant hypertension: a French experience].
    Benamer H; Mylotte D; Garcia-Alonso C; Unterseeh T; Garot P; Louvard Y; Lefevre T; Morice MC;
    Ann Cardiol Angeiol (Paris); 2013 Dec; 62(6):384-91. PubMed ID: 24182849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension.
    Mahfoud F; Ukena C; Schmieder RE; Cremers B; Rump LC; Vonend O; Weil J; Schmidt M; Hoppe UC; Zeller T; Bauer A; Ott C; Blessing E; Sobotka PA; Krum H; Schlaich M; Esler M; Böhm M
    Circulation; 2013 Jul; 128(2):132-40. PubMed ID: 23780578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood pressure response to catheter-based renal sympathetic denervation in severe resistant hypertension: data from the Greek Renal Denervation Registry.
    Tsioufis C; Ziakas A; Dimitriadis K; Davlouros P; Marketou M; Kasiakogias A; Thomopoulos C; Petroglou D; Tsiachris D; Doumas M; Skalidis E; Karvounis C; Alexopoulos D; Vardas P; Kallikazaros I; Stefanadis C; Papademetriou V; Tousoulis D
    Clin Res Cardiol; 2017 May; 106(5):322-330. PubMed ID: 27957627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal denervation using an irrigated catheter in patients with resistant hypertension: a promising strategy?
    Armaganijan L; Staico R; Moraes A; Abizaid A; Moreira D; Amodeo C; Sousa M; Borelli F; Armaganijan D; Sousa JE; Sousa A
    Arq Bras Cardiol; 2014 Apr; 102(4):355-63. PubMed ID: 24652055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma endothelin-1 levels in patients with resistant hypertension: effects of renal sympathetic denervation.
    Petramala L; Olmati F; Mancone M; Concistré A; Galassi M; Marinelli C; Tonnarini G; Lucia P; Costi U; Iannucci G; Sardella G; Letizia C
    Ann Med; 2017 Aug; 49(5):396-403. PubMed ID: 28084122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of catheter-based renal sympathetic denervation on 24-h ambulatory blood pressure in patients with resistant hypertension.
    Völz S; Andersson B; Manhem K; Haraldsson I; Rundqvist B
    Blood Press; 2014 Aug; 23(4):228-32. PubMed ID: 24432803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of renal denervation with a standard irrigated cardiac ablation catheter on blood pressure and renal function in patients with chronic kidney disease and resistant hypertension.
    Kiuchi MG; Maia GL; de Queiroz Carreira MA; Kiuchi T; Chen S; Andrea BR; Graciano ML; Lugon JR
    Eur Heart J; 2013 Jul; 34(28):2114-21. PubMed ID: 23786861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of catheter-based renal denervation on cardiac sympathetic activity and innervation in patients with resistant hypertension.
    Donazzan L; Mahfoud F; Ewen S; Ukena C; Cremers B; Kirsch CM; Hellwig D; Eweiwi T; Ezziddin S; Esler M; Böhm M
    Clin Res Cardiol; 2016 Apr; 105(4):364-71. PubMed ID: 26493305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Individual-patient visit-by-visit office and ambulatory blood pressure measurements over 24months in patients undergoing renal denervation for hypertension.
    Lambert T; Gammer V; Nahler A; Blessberger H; Kammler J; Grund M; Kerschner K; Buchmayr G; Saleh K; Kypta A; Hönig S; Wichert-Schmitt B; Schwarz S; Sihorsch K; Reiter C; Steinwender C
    Int J Cardiol; 2015 Feb; 181():96-101. PubMed ID: 25497527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of a multi-electrode renal sympathetic denervation system in resistant hypertension: the EnligHTN I trial.
    Worthley SG; Tsioufis CP; Worthley MI; Sinhal A; Chew DP; Meredith IT; Malaiapan Y; Papademetriou V
    Eur Heart J; 2013 Jul; 34(28):2132-40. PubMed ID: 23782649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal sympathetic denervation as second-line therapy in mild resistant hypertension: a pilot study.
    Kaltenbach B; Franke J; Bertog SC; Steinberg DH; Hofmann I; Sievert H
    Catheter Cardiovasc Interv; 2013 Feb; 81(2):335-9. PubMed ID: 22807098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catheter-based renal denervation for resistant hypertension: 12-month results of the EnligHTN I first-in-human study using a multielectrode ablation system.
    Papademetriou V; Tsioufis CP; Sinhal A; Chew DP; Meredith IT; Malaiapan Y; Worthley MI; Worthley SG
    Hypertension; 2014 Sep; 64(3):565-72. PubMed ID: 24935940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.